Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure
Cardiorenal Medicine · 2024
DOI: 10.1159/000538774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Gonzalo Núñez-Marín und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain. Hauptthemen laut MEDLINE: Heart Failure, Biomarkers, Diuretics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Introduction
This study aimed to evaluate the association between the NephroCheck® test AKIRisk® score, diuretic efficiency (DE), and the odds of worsening kidney function (WKF) within the first 72 h of admission in patients hospitalized for acute heart failure (AHF).
Methods
The study prospectively enrolled 125 patients admitted with AHF. NephroCheck® test was obtained within the first 24 h of admission. DE was defined as net fluid urine output per 40 mg of furosemide equivalents.
Results
The median AKIRisk® score was 0.11 (IQR 0.06–0.34), and 38 (30.4%) patients had an AKIRisk® score >0.3. The median cumulative DE at 72 h was 1,963 mL (IQR 1317–3,239 mL). At 72 h, a total of 10 (8%) patients developed an absolute increase in sCr ≥0.5 mg/dL (WKF). In a multivariable setting, there was an inverse association between the AKIRisk® score and DE within the first 72 h. In fact, the highest the AKIRisk® score (centered at 0.3), the higher the likelihood of poor DE (below the median) and WKF at 72 h (odds ratio [OR] 2.04; 95%; CI: 1.02–4.07; p = 0.043, and OR 3.31, 95% CI: 1.30–8.43; p = 0.012, respectively).
Conclusion
In patients with AHF, a higher NephroCheck® AKIRisk® score is associated with poorer DE and a higher risk of WKF at 72 h. Further research is needed to confirm the role of urinary cell cycle arrest biomarkers in the AHF scenario.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.
- Department of Nephrology, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
- Germans Trias I Pujol Research Institute (IGTP), REMAR- IGTP Group (Kidney-affecting Diseases Research Group), Badalona, Spain.
- International Renal Research Institute of Vicenza, Vicenza, Italy.
- Department of Nephrology, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.
- Department of Medicine, Universitat de València, Valencia, Spain.
Zitieren
APA
Núñez-Marín, G., Romero-González, G., Bover, J., Górriz, J. L., Bayés-Genís, A., Sanchis, J., Núñez, J., & de la Espriella, R. (2024). Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure. Cardiorenal Medicine. https://doi.org/10.1159/000538774
Vancouver
Núñez-Marín G, Romero-González G, Bover J, Górriz JL, Bayés-Genís A, Sanchis J, et al. Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure. Cardiorenal Medicine. 2024. doi:10.1159/000538774
BibTeX
@article{NezMarn2024,
author = {Núñez-Marín, Gonzalo and Romero-González, Gregorio and Bover, Jordi and Górriz, Jose Luis and Bayés-Genís, Antoni and Sanchis, Juan and Núñez, Julio and de la Espriella, Rafael},
title = {Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure},
journal = {Cardiorenal Medicine},
year = {2024},
doi = {10.1159/000538774}
}
EUVIMED